about
Using exercise to measure and modify cardiac functionCalcium signaling regulates ventricular hypertrophy during development independent of contraction or blood flow.Epigenetic mechanisms in heart development and diseasePost-translational modifications of the cardiac proteome in diabetes and heart failureEarly transcriptional alteration of histone deacetylases in a murine model of doxorubicin-induced cardiomyopathy.Epigenetic switch at atp2a2 and myh7 gene promoters in pressure overload-induced heart failure.Thyroid Hormone-Regulated Cardiac microRNAs are Predicted to Suppress Pathological Hypertrophic Signaling.Small heat shock protein 20 (Hsp20) facilitates nuclear import of protein kinase D 1 (PKD1) during cardiac hypertrophyCalcium-mediated histone modifications regulate alternative splicing in cardiomyocytes.Caffeine exposure alters cardiac gene expression in embryonic cardiomyocytes.A systematic review of fetal genes as biomarkers of cardiac hypertrophy in rodent models of diabetes.Comparative Characterization of Cardiac Development Specific microRNAs: Fetal Regulators for Future.cAMP induces hypertrophy and alters DNA methylation in HL-1 cardiomyocytes.The Heparan Sulfate Proteoglycan Glypican-6 Is Upregulated in the Failing Heart, and Regulates Cardiomyocyte Growth through ERK1/2 Signaling.STIM1 elevation in the heart results in aberrant Ca²⁺ handling and cardiomyopathySex differences in porcine left ventricular myocardial remodeling due to right ventricular pacing.MicroRNA 214 Is a Potential Regulator of Thyroid Hormone Levels in the Mouse Heart Following Myocardial Infarction, by Targeting the Thyroid-Hormone-Inactivating Enzyme Deiodinase Type IIICardiomyocyte-specific conditional knockout of the histone chaperone HIRA in mice results in hypertrophy, sarcolemmal damage and focal replacement fibrosis.Regeneration versus scarring in vertebrate appendages and heart.The E3 ligase Mule protects the heart against oxidative stress and mitochondrial dysfunction through Myc-dependent inactivation of Pgc-1α and Pink1.Cardiomyocyte changes in the metabolic syndrome and implications for endogeneous protective strategies.Harnessing the Therapeutic Potential of MicroRNAs for Cardiovascular Disease.Application of microRNAs in diagnosis and treatment of cardiovascular disease.Coordinating Regulation of Gene Expression in Cardiovascular Disease: Interactions between Chromatin Modifiers and Transcription Factors.Exogenous GDF11 induces cardiac and skeletal muscle dysfunction and wasting.Cardiac Fibroblast Transcriptome Analyses Support a Role for Interferogenic, Profibrotic and Inflammatory Genes in Anti-SSA/Ro-Associated Congenital Heart Block.Contextualizing Genetics for Regional Heart Failure CareMyocardial plasticity: cardiac development, regeneration and disease.Doxorubicin-induced chronic dilated cardiomyopathy-the apoptosis hypothesis revisited.Role of microRNA in diabetic cardiomyopathy: From mechanism to intervention.Overview of the Muscle Cytoskeleton.Ectopic expression of Cdk8 induces eccentric hypertrophy and heart failure.Regulatory Networks that Direct the Development of Specialized Cell Types in the Drosophila HeartThree-dimensional structure of the intercalated disc reveals plicate domain and gap junction remodeling in heart failure.ALDH2 attenuates Dox-induced cardiotoxicity by inhibiting cardiac apoptosis and oxidative stress.Timing and Targeting of Treatment in Left Ventricular Hypertrophy.Spatial detection of fetal marker genes expressed at low level in adult human heart tissue.Predictive model identifies key network regulators of cardiomyocyte mechano-signaling.Apocynin prevents isoproterenol-induced cardiac hypertrophy in rat.Meox1 accelerates myocardial hypertrophic decompensation through Gata4.
P2860
Q26994995-F07B48CE-C735-4E19-BD83-081B5AA79A3CQ27302362-81FAE642-F723-4CFB-9C36-68C38DEDAB9AQ28081134-C2551675-E83E-4702-BE0E-B4F69ADDAFA2Q33361067-62208626-871F-4B51-95F0-DC9054879CDBQ33853732-A8612156-88AE-4B33-829F-24979B43537FQ34121851-8792D5F1-3B90-40ED-A1A4-2E2845C30EADQ34369275-EC747381-082F-4B9B-A262-7B38A4A9E495Q34472503-01A240DA-550E-40AC-BE9D-CB7C86B4C7B6Q34581100-9AFD7ED5-BE75-49EC-94F3-5FCA277391AAQ34726685-0E8BA818-3C72-4A9F-86F1-0F362718D639Q35129485-158C3710-6297-4E13-AC39-F78AE117FA40Q35806442-0067137A-024C-4657-9206-9E9DC3560DACQ36066334-F6FC7180-5B91-48A2-B0AA-64CF7E1277F2Q36170775-8FE4D385-DC12-437E-9854-AF4C01917F72Q36260333-940E5911-518E-49C0-94F0-7BB6604D107CQ36364241-239D8537-81A6-4571-BCA4-5B62AD33B489Q36665561-2D8F4A4E-E3FC-45DA-9214-07FB66BDDEF9Q36802647-795E122D-B14E-4186-B159-5671151CDA7FQ37326008-D576C9B3-1A26-427F-A95D-FDEF22728EC0Q37620424-B5BF96BF-20F8-4F4B-B4A8-EAFA7E82D46EQ38191658-C861D789-4083-4B3A-A615-E9F2679D83EBQ38254809-A65B5BFD-7C5B-42CE-84E7-F589BC9D9E7AQ38264294-FCBF6FF3-CD25-49AC-99D7-08FD306356BBQ38692469-6D2B19EC-1DB8-4648-A858-858687BB9369Q38710240-BFD7CCD6-8DF7-4EDA-8540-7A3E05A1B71DQ38720234-6E3ED8A2-80CF-4086-9B59-8777AC7FDE8FQ38859880-9FB077CE-C197-4588-81CA-153BD416584BQ38920772-EC6909D8-F8E6-4706-BBFD-90A6363C237BQ39033784-6C409291-9957-470C-8958-B5CC55E60768Q39201286-8C0878ED-54C0-44F4-A0FA-292D288C3195Q39391006-0A143C86-95B4-443D-AFFE-94BE52E8828AQ41252423-F4B128C7-D721-494A-AD5E-4AB1C050DFC3Q41255173-F9C9C3CA-817E-422F-9993-0E14A57A1FB1Q41480706-A9AD3C3F-31ED-4E7D-8CF9-062457BB9876Q42061022-F7E2063F-0F47-480E-95B8-41F4BC0C4CA7Q42292429-F5BFE837-85B7-4246-9F28-DCD6FA169667Q42374965-5C6F85DC-EE1A-4E8B-928D-8F18A03798BFQ45072805-36C2B81F-65BC-433F-A0C5-FD0035E1ECACQ46236892-C0CD2FA9-C938-4A3B-A711-8EED248563FFQ47443287-23C2AE7E-3AB3-4632-B9D0-868A62F137B8
P2860
description
article científic
@ca
article scientifique
@fr
articol științific
@ro
articolo scientifico
@it
artigo científico
@gl
artigo científico
@pt
artigo científico
@pt-br
artikel ilmiah
@id
artikull shkencor
@sq
artículo científico
@es
name
Regulation of fetal gene expression in heart failure.
@en
type
label
Regulation of fetal gene expression in heart failure.
@en
prefLabel
Regulation of fetal gene expression in heart failure.
@en
P2093
P1476
Regulation of fetal gene expression in heart failure.
@en
P2093
Ellen Dirkx
Leon J De Windt
Paula A da Costa Martins
P304
P356
10.1016/J.BBADIS.2013.07.023
P407
P577
2013-09-10T00:00:00Z